Robotic colonoscopy just got a major upgrade. The FDA has granted 510(k) clearance to Neptune Medical's Triton 1 System — a robotic gastrointestinal endoscopy platform designed to enhance precision, stability, and control during colonoscopies. The system is cleared for use across the full colon, covering everything from routine screening and surveillance to more complex procedures like mucosal resections and submucosal dissections.

The clearance follows promising results from the first-in-human CARE 1 trial, which hit both of its primary endpoints and demonstrated strong performance across several key metrics — all without requiring patient repositioning, abdominal pressure, or a switch to manual colonoscopy.

By the Numbers:

• 100% cecal intubation rate (complete colon visualization)
• 0 adverse events reported in the CARE 1 trial
• 54.2% adenoma detection rate, surpassing the 35% industry threshold
• 67% lower average ergonomic burden vs. manual colonoscopy

Why it matters: Colonoscopy remains the gold standard for colorectal cancer screening, but physician fatigue and variability in technique can affect outcomes. A robotic system that improves detection rates while reducing physical strain on endoscopists could meaningfully raise the bar for both patient safety and procedural consistency.